MiMedx Group (MDXG) – Analyst EPS View
-
Needham & Company Reiterates Strong Buy on MiMedx Group (MDXG) Following 2Q Results
-
MiMedx Group (MDXG) PT Raised to $20 at Needham & Company; 'We Expect Wound RCTs to Drive Increased EpiFix Coverage and Adoption'
-
-
-
-
Back to MDXG Stock Lookup